Natasha B. Leighl, MD, MMSc, FRCPC, FASCO, FCAHS - Real Talk on Directions and Decisions in the Clinical Management of EGFRm NSCLC: Optimizing the Patient Journey Throughout the Disease Continuum
The episode discusses the clinical management of EGFRm NSCLC and optimizing the patient journey throughout the disease continuum.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RAU865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027. Real Talk on Directions and Decisions in the Clinical Management of EGFR m NSCLC: Optimizing the Patient Journey Throughout the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by independent educational grants from AstraZeneca, Black Diamond Therapeutics Inc, and Johnson & Johnson. Disclosure information is…
Sponsors
AstraZeneca, Black Diamond Therapeutics Inc, Johnson & Johnson
More episodes of PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast